title: Early lesions of follicular lymphoma: a genetic perspective.
abstract: The pathogenesis of follicular lymphoma is a multi-hit process progressing over many years through the accumulation of numerous genetic alterations. Besides the hallmark t(14;18), it is still unclear which other oncogenic hits contribute to the early steps of transformation and in which precursor stages these occur. To address this issue, we performed high-resolution comparative genomic hybridization microarrays on laser-capture micro-dissected cases of follicular lymphoma in situ (n=4), partial involvement by follicular lymphoma (n=4), and duodenal follicular lymphoma (n=4), assumed to represent, potentially, the earliest stages in the evolution of follicular lymphoma. Cases of reactive follicular hyperplasia (n=2), uninvolved areas from follicular lymphoma in situ lymph nodes, follicular lymphoma grade 1-2 (n=5) and follicular lymphoma grade 3A (n=5) were used as controls. Surprisingly, alterations involving several relevant (onco)genes were found in all entities, but at significantly lower proportions than in overt follicular lymphoma. While the number of alterations clearly assigns all these entities as precursors, the pattern of partial involvement by follicular lymphoma alterations was quantitatively and qualitatively closer to that of follicular lymphoma, indicating significant selective pressure in line with its faster rate of progression. Among the most notable alterations, we observed and validated deletions of 1p36 and gains of the 7p and 12q chromosomes and related oncogenes, which include some of the most recurrent oncogenic alterations in overt follicular lymphoma (TNFRSF14, EZH2, MLL2). By further delineating distinctive and hierarchical molecular and genetic features of early follicular lymphoma entities, our analysis underlines the importance of applying appropriate criteria for the differential diagnosis. It also provides a first set of candidates likely to be involved in the cascade of hits that pave the path of the various progression phases to follicular lymphoma development.
authors.affiliation: elainejaffe@nih.gov or nadel@ciml.univ-mrs.fr.
authors.forename: Emilie
authors.initials: E
authors.lastname: Mamessier
authors.forename: Joo Y
authors.initials: JY
authors.lastname: Song
authors.forename: Franziska C
authors.initials: FC
authors.lastname: Eberle
authors.forename: Svetlana
authors.initials: S
authors.lastname: Pack
authors.forename: Charlotte
authors.initials: C
authors.lastname: Drevet
authors.forename: Bruno
authors.initials: B
authors.lastname: Chetaille
authors.forename: Ziedulla
authors.initials: Z
authors.lastname: Abdullaev
authors.forename: José
authors.initials: J
authors.lastname: Adelaïde
authors.forename: Daniel
authors.initials: D
authors.lastname: Birnbaum
authors.forename: Max
authors.initials: M
authors.lastname: Chaffanet
authors.forename: Stefania
authors.initials: S
authors.lastname: Pittaluga
authors.forename: Sandrine
authors.initials: S
authors.lastname: Roulland
authors.forename: Andreas
authors.initials: A
authors.lastname: Chott
authors.forename: Elaine S
authors.initials: ES
authors.lastname: Jaffe
authors.forename: Bertrand
authors.initials: B
authors.lastname: Nadel
mesh_terms: D002278:Carcinoma in Situ / Q000235:genetics / Q000473:pathology; D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D055028:Comparative Genomic Hybridization; D018450:Disease Progression; D042822:Genomic Instability; D018858:Germinal Center / Q000473:pathology; D006801:Humans; D008224:Lymphoma, Follicular / Q000235:genetics* / Q000473:pathology*; D060787:Neoplasm Grading; D009367:Neoplasm Staging